By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche Diagnostics said this week that Cedars-Sinai Medical Center in Los Angeles will serve as a Roche Molecular Center of Excellence for the next five years. Cedars-Sinai offers prognostic and diagnostic tools for individualized molecular testing. One of the tests it will offer as an MCE is Roche's cobas 4800 BRAF V600 Mutation Test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.